{
    "Trade/Device Name(s)": [
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels",
        "MicroScan MICroSTREP plus Panel",
        "MicroScan MICroSTREP plus Panel Clindamycin (0.015 to 2 mcg/ml)"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062777",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "October 10, 2006",
    "Summary Letter Received Date": "September 18, 2006",
    "Submission Date": "August 28, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clindamycin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci",
        "Streptococcus pneumoniae"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Miniaturized broth dilution susceptibility test",
        "Instrument read method",
        "Manual visual read"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel Clindamycin assessing susceptibility of aerobic streptococci including S. pneumoniae using instrument and manual MIC determination.",
    "Indications for Use Summary": "Determination of quantitative and/or qualitative antimicrobial agent susceptibility of aerobic streptococci, including Streptococcus pneumoniae, using Clindamycin on the MicroScan MICroSTREP plus Panel with instrument read capability.",
    "fda_folder": "Microbiology"
}